XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
News
Current issue
Archival Issues
Search
Newsletter
Manuscript Submission
 » 
Journal Abstract
 
Results of entecavir treatment of chronic hepatitis B
Magdalena Rogalska-Płońska, Tadeusz Wojciech Łapiński
Medical Science Review - Hepatologia 2011; 11 44-46
aaICID: 970917
Article type: Review article
IC™ Value: 3.40
Abstract provided by Publisher
 
Hepatitis B virus is a main cause of chronic hepatitis regarding 350 million people
worldwide, leading to life-threatening conditions: liver cirrhosis and hepatocellular carcinoma.
The worsening progress may be blocked or delayed by the effective therapy. Entecavir
is an oral nucleoside analogue, safe and well tolerated, very effective inhibitor of HBV polymerase
resulting in rapid viral suppression, histological improvement and ALT normalization.
In several randomized, multicentre trials entecavir was effective in nucleoside-naïve and lamivudine-
refractory patients, hepatitis B e antigen positive or negative as well as patients with
decompensated liver cirrhosis.

ICID 970917

DOI 10.5604/17305039.970917
 
FULL TEXT 104 KB


Related articles
  • in IndexCopernicus™
         WZWB [0 related records]
         entekawir [1 related records]
         leczenie [371 related records]
         CHB [0 related records]
         Entecavir [0 related records]
         treatment [441 related records]


  •  

    Copyright © Medical Science Review - Hepatologia  2017
    Page created by Index Copernicus Ltd. All Rights reserved.